-
公开(公告)号:US20080070933A1
公开(公告)日:2008-03-20
申请号:US11844863
申请日:2007-08-24
申请人: Kenneth Huang , James Veal , Emilie Smith , Wei Ma
发明人: Kenneth Huang , James Veal , Emilie Smith , Wei Ma
IPC分类号: C07D473/00 , A61K31/416 , A61K31/52 , A61P31/00 , A61P35/00 , C07D231/54
CPC分类号: C07D473/34 , C07D231/56 , C07D473/32
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I, wherein A, R7, X1, X2, X3, Y, and n are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中A,R 7,X 1,X 2,X 3, / SUB,Y和n如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20080070935A1
公开(公告)日:2008-03-20
申请号:US11844584
申请日:2007-08-24
申请人: Kenneth Huang , James Veal , Thomas Barta , Emilie Smith , Wei Ma , Andy Ommen
发明人: Kenneth Huang , James Veal , Thomas Barta , Emilie Smith , Wei Ma , Andy Ommen
IPC分类号: A61K31/517 , A61K31/47 , A61K31/519 , A61P25/00 , A61P3/00 , A61P31/10 , A61P37/00 , C07D217/22 , C07D401/10 , C07D403/02 , C07D401/14 , C07D239/72 , A61P9/00 , A61P35/00 , A61P31/00 , A61P29/00 , A61P19/02 , A61K31/4725
CPC分类号: C07D403/04 , C07D401/04 , C07D401/14 , C07D471/04
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R0, R5, R6, R7, n, Q1-Q5, Y, and X1-X3 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R 0,R 5,R 6,R 7, ,n,Q 1 -Q 5,Y和X 1 -X 3 -X如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20080076800A1
公开(公告)日:2008-03-27
申请号:US11844629
申请日:2007-08-24
申请人: Kenneth Huang , Thomas Barta , Emilie Smith , Steven Hall , James Veal
发明人: Kenneth Huang , Thomas Barta , Emilie Smith , Steven Hall , James Veal
IPC分类号: A61K31/44 , A61K31/166 , A61K31/196 , A61K31/216 , A61K31/443 , A61P19/02 , A61P29/00 , A61P35/00 , A61P9/00 , C07D405/12 , C07D335/02 , C07D309/14 , C07D213/85 , C07D213/82 , C07D211/58 , C07C255/58 , C07C233/65 , C07C229/42 , A61P37/00 , A61P31/00 , A61P25/00 , A61K31/4465 , A61K31/277 , A61K31/351 , A61K31/382
CPC分类号: C07D213/84 , C07C255/58 , C07C255/59 , C07D211/58 , C07D213/81 , C07D213/82 , C07D213/85 , C07D309/14 , C07D335/02 , C07D405/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein A, Q1, Q2, Q3, R3, R4, R5, RO, m, and p are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中A 1,Q 1,Q 2,Q 3,R 3, R 4,R 5,R 5,R O,m和p如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20080070930A1
公开(公告)日:2008-03-20
申请号:US11844456
申请日:2007-08-24
申请人: Kenneth Huang , Emilie Smith , James Veal
发明人: Kenneth Huang , Emilie Smith , James Veal
IPC分类号: C07D403/04 , A61K31/497 , A61K31/506 , C07D403/14 , A61P31/00 , A61P35/00
CPC分类号: C07D409/14 , C07D401/14 , C07D403/04 , C07D405/14
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R0, R3, R7, n, Q1, Q2, Y, and X1-X3 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R 0,R 3,R 7,n,Q 1, Q 1,Y 2和X 1 -X 3如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20060041135A1
公开(公告)日:2006-02-23
申请号:US11254895
申请日:2005-10-20
申请人: Daniel Comins , Emilie Smith
发明人: Daniel Comins , Emilie Smith
IPC分类号: C07F7/02 , C07D403/04
CPC分类号: C07D401/04 , C07F7/0814
摘要: Methods of synthesizing nicotine analogs and derivatives are described. In some embodiments the methods utilize an alkyl or aryl silyl-substituted nicotine analog intermediate. Intermediates useful for the synthesis of nicotine and nicotine analogs are also described.
-
公开(公告)号:US07304160B2
公开(公告)日:2007-12-04
申请号:US11463986
申请日:2006-08-11
申请人: Laura S. King , Emilie Smith , Daniel L. Comins
发明人: Laura S. King , Emilie Smith , Daniel L. Comins
IPC分类号: C07D401/04 , C07D413/04 , C07D417/04 , C07D419/04
CPC分类号: C07D401/04 , C07F7/0814
摘要: Methods of synthesizing nicotine analogs and derivatives are described. The methods are particularly useful for the regioselective production of enantiomerically pure nicotine anlogs having substituents at the C4 position. Intermediates useful for the synthesis of such compounds are also described.
摘要翻译: 描述了合成尼古丁类似物和衍生物的方法。 该方法对于区域选择性生产在C4位具有取代基的对映体纯的尼古丁肛门特别有用。 还描述了可用于合成这些化合物的中间体。
-
公开(公告)号:US07112678B2
公开(公告)日:2006-09-26
申请号:US10715147
申请日:2003-11-17
申请人: Laura S. King , Emilie Smith , Daniel L. Comins
发明人: Laura S. King , Emilie Smith , Daniel L. Comins
IPC分类号: C07D401/04 , C07F7/08
CPC分类号: C07D401/04 , C07F7/0814
摘要: Methods of synthesizing nicotine analogs and derivatives are described. The methods are particularly useful for the regioselective production of enantiomerically pure nicotine anlogs having substituents at the C4 position. Intermediates useful for the synthesis of such compounds are also described.
摘要翻译: 描述了合成尼古丁类似物和衍生物的方法。 该方法对于区域选择性生产在C4位具有取代基的对映体纯的尼古丁肛门特别有用。 还描述了可用于合成这些化合物的中间体。
-
公开(公告)号:US20060189812A1
公开(公告)日:2006-08-24
申请号:US11413281
申请日:2006-04-28
申请人: Daniel Comins , Florence Fevrier , Emilie Smith
发明人: Daniel Comins , Florence Fevrier , Emilie Smith
IPC分类号: C07D403/04 , C07F1/02
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/695 , C07F7/0814
摘要: A first aspect of the present invention is a method for of making a compound of Formula Ia or Formula Ib: wherein X is halo, by (a) metalating a precursor compound to form an organometallic intermediate, and then reacting the organometallic intermediate with a halogenating agent to produce the compound of Formula Ia or Formula Ib.
-
公开(公告)号:US20070021469A1
公开(公告)日:2007-01-25
申请号:US11536180
申请日:2006-09-28
申请人: Daniel Comins , Emilie Smith
发明人: Daniel Comins , Emilie Smith
IPC分类号: A61K31/4439 , C07D403/04
CPC分类号: C07D401/04 , C07F7/0814
摘要: Methods of synthesizing nicotine analogs and derivatives are described. In some embodiments the methods utilize an alkyl or aryl silyl-substituted nicotine analog intermediate. Intermediates useful for the synthesis of nicotine and nicotine analogs are also described.
摘要翻译: 描述了合成尼古丁类似物和衍生物的方法。 在一些实施方案中,所述方法利用烷基或芳基甲硅烷基取代的尼古丁类似物中间体。 还描述了可用于合成尼古丁和尼古丁类似物的中间体。
-
10.
公开(公告)号:US20050131030A1
公开(公告)日:2005-06-16
申请号:US10926821
申请日:2004-08-26
申请人: Daniel Comins , Florence Fevrier , Emilie Smith
发明人: Daniel Comins , Florence Fevrier , Emilie Smith
IPC分类号: A61K31/4439 , A61K31/695 , C07F7/08 , C07F1/02 , C07F7/02 , C07D43/04
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/695 , C07F7/0814
摘要: A first aspect of the present invention is a method for of making a compound of Formula Ia or Formula Ib: wherein X is halo, by (a) metalating a precursor compound to form an organometallic intermediate, and then reacting the organometallic intermediate with a halogenating agent to produce the compound of Formula Ia or Formula Ib.
摘要翻译: 本发明的第一方面是制备式Ia或式Ib化合物的方法:其中X为卤素,(a)使前体化合物金属化形成有机金属中间体,然后使有机金属中间体与卤化反应 试剂以产生式Ia或式Ib的化合物。
-
-
-
-
-
-
-
-
-